AR and posterior cortical atrophy: A recent in vivo preclinical mouse study found that Rb1 loss promotes plasticity and metastasis in PCa with TP53, and tumor suppressor phosphatase and tensin homolog (Pten) loss causes secondary resistance to therapies that target the AR signal axis[101].